Approximately 50% of the sarcomas expressed PD-L1 by IHC and presented with PD-1+ TILs, notably the LMS, chondrosarcomas, liposarcomas and UPS. This evidence concerns the gene PDCD1 and undifferentiated pleomorphic sarcoma.